Table 1.
Mode | Object of study | Intervention mode | Conclusion | Ref |
A | Mice | Melatonin | Melatonin protects against sepsis-induced cardiac dysfunction by regulating apoptosis and autophagy via activation of SIRT1 in mice. | [49] |
A | Septic mice | TMZ | TMZ protected against LPS-induced myocardial dysfunction and apoptosis, accompanied by inhibition of macrophage pro-inflammatory responses. | [50] |
P | Mice | TMZ | TMZ as a potential therapeutic agent for septic or endotoxemia-associated cardiac dysfunction in mice. | [45] |
A | Rats | miR-25 | miR-25 inhibits sepsis-induced cardiomyocyte apoptosis by targeting PTEN. | [51] |
A | Septic rats | AC2-26 | AC2-26 may alleviate the sepsis-induced cardiomyocyte apoptosis in vivo and in vivo through the LXA4/PI3K/AKT signaling pathway. | [52] |
A | Septic rats | Calpain inhibitors | Akt/eNOS/NO pathway might lead to a novel pharmacological therapy for cardiomyocytes apoptosis in sepsis. | [53] |
A | Septic rats | Esmolol | Esmolol reduces apoptosis and inflammation in early sepsis rats with abdominal infection. | [54] |
P and A | Mice | Stimulator of interferon genes | STING-IRF3 contributes to LPS-induced cardiac dysfunction, inflammation, apoptosis, and pyroptosis by activating NLRP3. | [55] |
P | HCM cells | Angiotensin II | miR-133a-3p upregulation may be a promising strategy for cardiac hypertrophy treatment. | [56] |
P | H9C2 rat cardiomyoblast cell | LPS | LPS aggravates high glucose- and hypoxia/reoxygenation-induced injury through activating ROS-dependent NLRP3 inflammasome-mediated pyroptosis in H9C2 cardiomyocytes. | [57] |
P | Septic BALB/c mice | Thymoquinone | Role of thymoquinone in cardiac damage caused by sepsis from BALB/c mice. | [58] |
P | LPS-treated mice | Geniposide | Geniposide protects against sepsis-induced myocardial dysfunction through the AMPKα-dependent pathway. | [59] |
P | A mouse hyperuricemia model | IR (MI/R) | UA aggravates MI/R-induced activation of the NLRP3 inflammatory cascade and pyroptosis by promoting ROS generation, while inflammasome inhibitors and ROS scavengers partly reverse the injury. | [60] |
P | LPS-induced mice/CORM-3-treated mice | CO-releasing molecule-3 | Carbon monoxide releasing molecule-3 improves myocardial function in mice with sepsis by inhibiting NLRP3 inflammasome activation in cardiac fibroblasts. | [61] |
N | Mice lacking CypD | CypD-deficient mice by gene targeting | The CypD-dependent mPT regulates some forms of necrotic death, but not apoptotic death. | [10] |
N | Mouse | CypD or RIP3 knockout | RIP3–CaMKII–MPTP myocardial necroptosis pathway, a promising target for the treatment of ischemia- and oxidative stress-induced myocardial damage and heart failure. | [62] |
N | Heart failure patients | Detection of the level of death receptor | Necrosis-related factor and miR-873 can regulate programmed necrosis in the heart. | [63] |
Au | Domestic swine | IR (MI/R) | Autophagy, triggered by ischemia, could be a homeostatic mechanism, by which apoptosis is inhibited and the deleterious effects of chronic ischemia are limited. | [35] |
Au | Sepsis-induced rats | Melatonin | The study sheds light on the important role of Beclin-1 acetylation in regulating autophagy in sepsis and suggests that melatonin is a potential candidate drug for the treatment of sepsis. | [64] |
Au | H9C2 rat cardiomyoblast cell | Hypoxia/reoxygenation (H/R) | miR-542-5p/autophagy pathway might be a potential target for the treatment of H/R-related heart diseases. | [65] |
A: Apoptosis; Au: Autophagy; CypD: Cyclophilin D; IR: Ischemia-reperfusion; LPS: Lipopolysaccharides; MPTP: Mitochondrial permeability transition pore; N: Necrosis; NLRP3: Nucleotide-binding oligomerization domain-like receptor protein 3; P: Pyroptosis; ROS: Reactive oxygen species; TMZ: Trimetazidine; AC2-26: an active N-terminal peptide of AnxA1(Annexin A1); MI/R: Myocardial ischemia reperfusion; CO: Carbon monoxide; mPT: Mitochondrial permeability transition; RIP3:Receptor-interacting serine-threonine kinase 3.